Excellent Result With the Use of Single-Dose OK-432 in Cervical Macrocystic Lymphangioma
 
Yazarlar (7)
Nihal Efe
Enver Altas
Muhammet Recai Mazlumoglu
Bulent Aktan
Harun Ucuncu
Suat Eren
Makale Türü Özgün Makale (ESCI dergilerinde yayınlanan tam makale)
Dergi Adı JOURNAL OF CRANIOFACIAL SURGERY
Dergi ISSN 1049-2275 Wos Dergi Scopus Dergi
Makale Dili İngilizce Basım Tarihi 10-2016
Cilt / Sayı / Sayfa 27 / 7 / 1802–1803 DOI 10.1097/SCS.0000000000002983
Makale Linki https://journals.lww.com/jcraniofacialsurgery/fulltext/2016/10000/Excellent_Result_With_the_Use_of_Single_Dose.46.aspx
UAK Araştırma Alanları
Özet
Though the lymphangioma is a benign neoplasm, it may make an invasion to vital structures by progressively growing. For lymphangioma, which progressed in such a way, surgical treatment has high morbidity and recurrence risk. On these cases, OK-432 is a frequently used sclerotherapy agent. The authors report the result they obtained by the use of single-dose OK-432 on an inoperable pediatric cervical macrocystic lymphangioma case and also their experiences.
Anahtar Kelimeler
Cervical macrocystic lymphangioma | OK-432 | sclerotherapy
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları
Web of Science 7
Google Scholar 9
Excellent Result With the Use of Single-Dose OK-432 in Cervical Macrocystic Lymphangioma

Paylaş